Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Research ArticleCLINICAL INVESTIGATIONS

Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Predict Response to CRT?

Maureen M. Henneman, Ji Chen, Petra Dibbets-Schneider, Marcel P. Stokkel, Gabe B. Bleeker, Claudia Ypenburg, Ernst E. van der Wall, Martin J. Schalij, Ernest V. Garcia and Jeroen J. Bax
Journal of Nuclear Medicine July 2007, 48 (7) 1104-1111; DOI: https://doi.org/10.2967/jnumed.107.039925
Maureen M. Henneman
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ji Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Petra Dibbets-Schneider
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marcel P. Stokkel
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabe B. Bleeker
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Ypenburg
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernst E. van der Wall
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin J. Schalij
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ernest V. Garcia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jeroen J. Bax
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • FIGURE 1. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 1. 

    (A) Changes in LVEDV from baseline (white bars) to 6-mo follow-up (black bars) in responders and nonresponders to CRT. LVEDV decreased significantly in responders and remained unchanged in nonresponders. *P < 0.0001 baseline vs. 6-mo follow-up. (B) Changes in LVESV from baseline (white bars) to 6-mo follow-up (black bars) in responders and nonresponders to CRT. LVESV decreased significantly in responders and remained unchanged in nonresponders. *P < 0.0001 baseline vs. 6-mo follow-up. (C) Changes in LVEF from baseline (white bars) to 6-mo follow-up (black bars) in responders and nonresponders to CRT. LVEF increased significantly in responders and remained unchanged in nonresponders. *P < 0.0001 baseline vs. 6-mo follow-up.

  • FIGURE 2. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 2. 

    (A) Example of phase analysis in a nonresponder to CRT. At baseline, no LV dyssynchrony with phase analysis was present in this patient. Nonnormalized (top panel) and normalized (bottom panel) phase distributions are relatively uniform and the corresponding phase histograms are highly peaked, narrow distributions. After 6-mo follow-up, no response to CRT was observed, as reflected by deterioration in NYHA functional class from 3 to 4. In addition, LVEF remained unchanged (baseline [32%] vs. 6-mo follow-up [33%]). (B) Example of phase analysis in a responder to CRT. In this patient, LV dyssynchrony with phase analysis was present at baseline. Nonnormalized (top panel) and normalized (bottom panel) phase distributions show substantial nonuniformity, whereas the corresponding phase histograms are widely spread distributions. After 6-mo follow-up, this patient improved in NYHA functional class from 3 to 2, indicating response to CRT. In addition, LVEF increased from 27% at baseline to 33% at 6-mo follow-up.

  • FIGURE 3. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 3. 

    ROC analysis of histogram bandwidth demonstrated a sensitivity and specificity of 70% to predict response to CRT at cutoff level of 135° for histogram bandwidth.

  • FIGURE 4. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 4. 

    ROC curve analysis of phase SD demonstrated a sensitivity and specificity of 74% to predict response to CRT at cutoff level of 43° for phase SD.

  • FIGURE 5. 
    • Download figure
    • Open in new tab
    • Download powerpoint
    FIGURE 5. 

    Comparison of difference of phases obtained when 8 frames per cycle (left panel) or 16 frames per cycle (right panel) data acquisition are used. Points in right panel are counts of a pixel arbitrarily chosen from the anterior region of polar maps given by a set of gated (16 frames per cycle) short-axis images. These points are regional maximum counts and their variations represent wall thickness changes at region over the cardiac cycle. Points in left panel are down-sampled from points in right panel. Curves are the first harmonics that approximate wall thickness changes during the cardiac cycle. With first harmonic approximation, phase difference between 8 frames per cycle and 16 frames per cycle is very small at −0.5° (360° corresponds to 1 cardiac cycle).

Tables

  • Figures
    • View popup
    TABLE 1

    Clinical Characteristics of Study Population (n = 42)

    Clinical characteristicValue
    Age (y)67 ± 9
    Men31 (74)
    Ischemic cardiomyopathy28 (67)
    Idiopathic dilated cardiomyopathy14 (33)
    Previous infarction24 (57)
    Q wave on electrocardiogram18 (43)
    QRS duration (ms)153 ± 32
    2D echocardiographic variables
     LVEDV (mL)251 ± 87
     LVESV (mL)193 ± 83
     LVEF (%)24 ± 7
    6-min walk test (m)330 ± 109
    Quality-of-life score37 ± 18
    NYHA class2.9 ± 0.4
    • Data are presented as mean ± SD or as number (%).

    • View popup
    TABLE 2

    Baseline Characteristics of Responders (n = 30) vs. Nonresponders (n = 12) to CRT

    Baseline characteristicRespondersNonrespondersP value
    Age (y)67 ± 866 ± 11NS
    Men22 (73)9 (75)NS
    Ischemic cardiomyopathy19 (63)9 (75)NS
    Idiopathic dilated cardiomyopathy11 (37)3 (25)NS
    Previous infarction17 (57)7 (58)NS
    Q wave on electrocardiogram11 (37)7 (58)NS
    2D echocardiographic variables
     LVEDV (mL)267 ± 88212 ± 74NS
     LVESV (mL)209 ± 88154 ± 55NS
     LVEF (%)23 ± 727 ± 8NS
    6-min walk test (m)345 ± 104289 ± 117NS
    Quality-of-life score35 ± 1743 ± 18NS
    NYHA class2.9 ± 0.32.8 ± 0.6NS
    GMPS variables
     Histogram bandwidth (°)175 ± 63117 ± 51<0.01
     Phase SD (°)56.3 ± 19.937.1 ± 14.4<0.01
    • NS = not statistically significant.

    • Data are presented as mean ± SD or as number (%).

PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 48 (7)
Journal of Nuclear Medicine
Vol. 48, Issue 7
July 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Predict Response to CRT?
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Predict Response to CRT?
Maureen M. Henneman, Ji Chen, Petra Dibbets-Schneider, Marcel P. Stokkel, Gabe B. Bleeker, Claudia Ypenburg, Ernst E. van der Wall, Martin J. Schalij, Ernest V. Garcia, Jeroen J. Bax
Journal of Nuclear Medicine Jul 2007, 48 (7) 1104-1111; DOI: 10.2967/jnumed.107.039925

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Predict Response to CRT?
Maureen M. Henneman, Ji Chen, Petra Dibbets-Schneider, Marcel P. Stokkel, Gabe B. Bleeker, Claudia Ypenburg, Ernst E. van der Wall, Martin J. Schalij, Ernest V. Garcia, Jeroen J. Bax
Journal of Nuclear Medicine Jul 2007, 48 (7) 1104-1111; DOI: 10.2967/jnumed.107.039925
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • CONCLUSION
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications
  • The Prognostic Value of Diastolic and Systolic Mechanical Left Ventricular Dyssynchrony Among Patients With Coronary Heart Disease
  • Utility of Equilibrium Radionuclide Angiogram-Derived Measures of Dyssynchrony to Predict Outcomes in Heart Failure Patients Undergoing Cardiac Resynchronization Therapy
  • Presence of Postsystolic Shortening Increases the Likelihood of Coronary Artery Disease: A Rest Electrocardiography-Gated Myocardial Perfusion SPECT Study
  • On the Importance of Image Gating for the Assay of Left Ventricular Mechanical Dyssynchrony Using SPECT
  • Imaging for Planning of Cardiac Resynchronization Therapy
  • A Prospective Pilot Study to Evaluate the Relationship Between Acute Change in Left Ventricular Synchrony After Cardiac Resynchronization Therapy and Patient Outcome Using a Single-Injection Gated SPECT Protocol
  • Nonechocardiographic Imaging in Evaluation for Cardiac Resynchronization Therapy
  • Long-term prognostic value of left ventricular dyssynchrony assessment by phase analysis from myocardial perfusion imaging
  • Left ventricular dyssynchrony assessment by phase analysis from gated myocardial perfusion SPECT: moving beyond conventional criteria
  • Agreement Is Poor Among Current Criteria Used to Define Response to Cardiac Resynchronization Therapy
  • Echocardiography and Noninvasive Imaging in Cardiac Resynchronization Therapy: Results of the PROSPECT (Predictors of Response to Cardiac Resynchronization Therapy) Study in Perspective
  • Quantitative Gated SPECT-Derived Phase Analysis on Gated Myocardial Perfusion SPECT Detects Left Ventricular Dyssynchrony and Predicts Response to Cardiac Resynchronization Therapy
  • Imaging Cardiac Resynchronization Therapy
  • The Year in Cardiac Imaging
  • Automatic Global and Regional Phase Analysis from Gated Myocardial Perfusion SPECT Imaging: Application to the Characterization of Ventricular Contraction in Patients with Left Bundle Branch Block
  • Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Preferably Predict Response to CRT?
  • Reply: Can LV Dyssynchrony as Assessed with Phase Analysis on Gated Myocardial Perfusion SPECT Preferably Predict Response to CRT?
  • Google Scholar

More in this TOC Section

  • Cardiac Presynaptic Sympathetic Nervous Function Evaluated by Cardiac PET in Patients with Chronotropic Incompetence Without Heart Failure
  • Validation and Evaluation of a Vendor-Provided Head Motion Correction Algorithm on the uMI Panorama PET/CT System
  • Efficacy and Safety of 124I-MIBG Dosimetry-Guided High-Activity 131I-MIBG Therapy of Advanced Pheochromocytoma or Neuroblastoma
Show more Clinical Investigations

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire